Net profit for Q4 came in at ₹656.6 crore, below the CNBC-TV18 poll estimate of ₹680 crore. Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) stood at ₹1,210.5 crore, slightly ahead of the poll estimate of ₹1,200 crore.
On a year-on-year basis, profit rose 19.2% from ₹550.9 crore, while revenue increased 18.9% to ₹17,683.9 crore from ₹14,871.9 crore. EBITDA grew 26.7% to ₹1,210.5 crore from ₹955.1 crore in the year-ago period. Operating margins expanded to 6.85% from 6.42% a year earlier.
Separately, the company announced key management changes. Hitesh Shah has been appointed as Chief Business Officer for Pharmacy and Food Services.
Director Chandrashekhar Bhave will step down from the board effective May 16, while Ravi Sharma has been appointed as Internal Auditor for FY27. According to the company’s investor presentation, the retailer continued its expansion trajectory, reaching 500 stores during FY26.
